newsfilter
← Latest News
Business Wire·

Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device

MIUDELLA® is a strategic addition to Organon's portfolio, strengthening its long‑term commitment to advancing women's health Organon (NYSE:OGN), a global healthcare company with a mission to deliver impactful